Artificial Intelligence Assessment of Chest Radiographs for COVID-19.

Journal: Clinical lymphoma, myeloma & leukemia
Published Date:

Abstract

BACKGROUND: The sensitivity of reverse-transcription polymerase chain reaction (RT-PCR) is limited for diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Chest computed tomography (CT) is reported to have high sensitivity; however, given the limited availability of chest CT during a pandemic, the assessment of more readily available imaging, such as chest radiographs, augmented by artificial intelligence may substitute for the detection of the features of coronavirus disease 2019 (COVID-19) pneumonia.

Authors

  • Koji Sasaki
    Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Guillermo Garcia-Manero
    Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Masayuki Nigo
    Division of Infectious Diseases, Department of Internal Medicine, The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX, United States; School of Biomedical Informatics, University of Texas Health Science Center at Houston, Houston, TX, United States. Electronic address: masayuki.nigo@uth.tmc.edu.
  • Elias Jabbour
    Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Farhad Ravandi
    Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • William G Wierda
    Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Nitin Jain
    Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Koichi Takahashi
    Department of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA.
  • Guillermo Montalban-Bravo
    Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Naval G Daver
    Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Philip A Thompson
    Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Naveen Pemmaraju
    Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Dimitrios P Kontoyiannis
    Department of Infectious Disease, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Junya Sato
    Faculty of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka, 5650871, Japan.
  • Sam Karimaghaei
    McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX.
  • Kelly A Soltysiak
    Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Issam I Raad
    Department of Infectious Disease, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Hagop M Kantarjian
    Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Brett W Carter
    Department of Thoracic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.